← Back to all trials
Completed
NCT06477068
Effect of a Medication Reminder Mobile Application
Conditions: Infertility
Sex: Female
Ages: 18 Years – 40 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 387
Sponsor: Hung Vuong Hospital
Location: Hung Vuong Ho Chi Minh City
Summary
The goal of this clinical trial is to evaluate of effectiveness when using the "telemedicine medication reminder app on smartphones" at the Infertility Department of Hung Vuong Hospital. The main questions it aims to answer are:
Comparison of the medication forgetting rate between the group of patients using the product and the group of patients not using the app.
Assessment of the level of patient satisfaction when using the app. Comparison of the quantity and quality outcomes of eggs between the group of patients using the app and the group of patients not using the app.
Participants will:
Using or not using " "telemedicine medication reminder app on smartphones" Record the number of cycle cancellations, number of missed doses, satisfaction rates, number of retrieved oocytes, number of mature oocytes, number of immature oocytes, and number of abnormal oocytes.
Eligibility Criteria
Inclusion Criteria:
* To eliminate factors that may affect egg quality, we selected patients with good prognosis for the study (18-\< 40 years old, undergoing IVF treatment for the first time).
* Indicated for ovarian stimulation for IVF treatment.
* Be able to use a smartphone.
* No underlying diseases: Diabetes mellitus, Increased prolactin, Thyroid dysfunction, and Adrenal disorders.
* Voluntary participate in the study and agree to sign the consent form.
Exclusion Criteria:
* BMI \> 30.
* IVF patient with oocyte donation.
* Reduced ovarian reserve.
* Contraindications for using ovarian stimulation drugs.
* Endocrine or metabolic disorders, any underlying diseases (kidney, liver, or heart disease).
* Subjects unwilling to participate in the study.
* Patients who are unable to comply with the study protocol: not using a smartphone, missing appointments for follow-up visits, unable to read or write in Vietnamese.
Source: ClinicalTrials.gov (NCT06477068). StuddyBuddy aggregates publicly available trial information.